Inflammasomes on the Crossroads of Innate Immune Recognition and Metabolic Control

Cell Metabolism

Volumn 26, Issue 1, 2017, Pages 71-93

  Próchnicki, Tomasz ^a   Latz, Eicke ^a,b,c,d  

^a UNIVERSITY HOSPITAL BONN   (Germany)

^b UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^c GERMAN CENTER FOR NEURODEGENERATIVE DISEASES DZNE   (Germany)

^d NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

Author keywords

glycolysis; gut microbiome; immunometabolism; inflammasome; innate immunity; mitochondria; NLRP3; NLRP6; pyrin; tricarboxylic acid cycle

Indexed keywords

CRYOPYRIN; G PROTEIN COUPLED RECEPTOR; INFLAMMASOME; ISOPRENOID; LIGAND; NLRP12 PROTEIN; NLRP6 PROTEIN; SATURATED FATTY ACID; UNCLASSIFIED DRUG; NLRP12 PROTEIN, HUMAN; NLRP6 PROTEIN, HUMAN; SIGNAL PEPTIDE;

AGONIST; ANTIGEN RECOGNITION; BACTERIAL METABOLISM; BIOSYNTHESIS; COLON FLORA; DIET; EXTRACELLULAR MATRIX; FATTY ACID METABOLISM; GLYCOLYSIS; HOST CELL; HOST PATHOGEN INTERACTION; HUMAN; IMMUNOREACTIVITY; IMMUNOREGULATION; INNATE IMMUNITY; INTESTINE FLORA; METABOLIC REGULATION; MICROFLORA; MITOCHONDRIAL RESPIRATION; MITOCHONDRION; MOLECULAR WEIGHT; NONHUMAN; PRIORITY JOURNAL; REVIEW; SALMONELLA; SIGNAL TRANSDUCTION; SPECIES COMPOSITION; ANIMAL; BACTERIAL INFECTION; BACTERIUM; IMMUNOLOGY; METABOLISM; MICROBIOLOGY;

ANIMALS; BACTERIA; BACTERIAL INFECTIONS; GASTROINTESTINAL MICROBIOME; GLYCOLYSIS; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNITY, INNATE; INFLAMMASOMES; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; METABOLIC NETWORKS AND PATHWAYS; MITOCHONDRIA; NLR FAMILY, PYRIN DOMAIN-CONTAINING 3 PROTEIN;

EID: 85028704665     PISSN: 15504131     EISSN: 19327420     Source Type: Journal    
DOI: 10.1016/j.cmet.2017.06.018     Document Type: Review

References (190)

1. Aktan, F., iNOS-mediated nitric oxide production and its regulation. Life Sci. 75 (2004), 639–653.
2. Akula, M.K., Shi, M., Jiang, Z., Foster, C.E., Miao, D., Li, A.S., Zhang, X., Gavin, R.M., Forde, S.D., Germain, G., et al. Control of the innate immune response by the mevalonate pathway. Nat. Immunol. 17 (2016), 922–929.
3. Altaf, A., Qu, P., Zhao, Y., Wang, H., Lou, D., Niu, N., NLRP3 inflammasome in peripheral blood monocytes of acute coronary syndrome patients and its relationship with statins. Coron. Artery Dis. 26 (2015), 409–421.
4. Antonopoulos, A.S., Margaritis, M., Lee, R., Channon, K., Antoniades, C., Statins as anti-inflammatory agents in atherogenesis: molecular mechanisms and lessons from the recent clinical trials. Curr. Pharm. Des. 18 (2012), 1519–1530.
5. Antonopoulos, C., Russo, H.M., El Sanadi, C., Martin, B.N., Li, X., Kaiser, W.J., Mocarski, E.S., Dubyak, G.R., Caspase-8 as an effector and regulator of NLRP3 inflammasome signaling. J. Biol. Chem. 290 (2015), 20167–20184.
6. Arsenijevic, D., Onuma, H., Pecqueur, C., Raimbault, S., Manning, B.S., Miroux, B., Couplan, E., Alves-Guerra, M.C., Goubern, M., Surwit, R., et al. Disruption of the uncoupling protein-2 gene in mice reveals a role in immunity and reactive oxygen species production. Nat. Genet. 26 (2000), 435–439.
7. Ballak, D.B., Stienstra, R., Tack, C.J., Dinarello, C.A., van Diepen, J.A., IL-1 family members in the pathogenesis and treatment of metabolic disease: focus on adipose tissue inflammation and insulin resistance. Cytokine 75 (2015), 280–290.
8. Bauernfeind, F.G., Horvath, G., Stutz, A., Alnemri, E.S., MacDonald, K., Speert, D., Fernandes-Alnemri, T., Wu, J., Monks, B.G., Fitzgerald, K.A., et al. Cutting edge: NF-kappaB activating pattern recognition and cytokine receptors license NLRP3 inflammasome activation by regulating NLRP3 expression. J. Immunol. 183 (2009), 787–791.
9. Birchenough, G.M.H., Johansson, M.E., Gustafsson, J.K., Bergström, J.H., Hansson, G.C., New developments in goblet cell mucus secretion and function. Mucosal Immunol. 8 (2015), 712–719.
10. Birchenough, G.M.H., Nyström, E.E., Johansson, M.E., Hansson, G.C., A sentinel goblet cell guards the colonic crypt by triggering Nlrp6-dependent Muc2 secretion. Science 352 (2016), 1535–1542.
11. Biswas, S.K., Mantovani, A., Orchestration of metabolism by macrophages. Cell Metab. 15 (2012), 432–437.
12. Błażejewski, A.J., Thiemann, S., Schenk, A., Pils, M.C., Gálvez, E.J.C., Roy, U., Heise, U., de Zoete, M.R., Flavell, R.A., Strowig, T., Microbiota normalization reveals that canonical caspase-1 activation exacerbates chemically induced intestinal inflammation. Cell Rep. 19 (2017), 2319–2330.
13. Bolon, C., Gauthier, C., Simonnet, H., Glycolysis inhibition by palmitate in renal cells cultured in a two-chamber system. Am. J. Physiol. 273 (1997), C1732–C1738.
14. Boyden, E.D., Dietrich, W.F., Nalp1b controls mouse macrophage susceptibility to anthrax lethal toxin. Nat. Genet. 38 (2006), 240–244.
15. Bray, S.J., Notch signalling in context. Nat. Rev. Mol. Cell Biol. 17 (2016), 722–735.
16. Broz, P., Dixit, V.M., Inflammasomes: mechanism of assembly, regulation and signalling. Nat. Rev. Immunol. 16 (2016), 407–420.
17. Broz, P., Newton, K., Lamkanfi, M., Mariathasan, S., Dixit, V.M., Monack, D.M., Redundant roles for inflammasome receptors NLRP3 and NLRC4 in host defense against Salmonella. J. Exp. Med. 207 (2010), 1745–1755.
18. Camell, C., Goldberg, E., Dixit, V.D., Regulation of Nlrp3 inflammasome by dietary metabolites. Semin. Immunol. 27 (2015), 334–342.
19. Chalfant, C.E., Kishikawa, K., Mumby, M.C., Kamibayashi, C., Bielawska, A., Hannun, Y.A., Long chain ceramides activate protein phosphatase-1 and protein phosphatase-2A. Activation is stereospecific and regulated by phosphatidic acid. J. Biol. Chem. 274 (1999), 20313–20317.
20. Chen, L., Wilson, J.E., Koenigsknecht, M.J., Chou, W.C., Montgomery, S.A., Truax, A.D., Brickey, W.J., Packey, C.D., Maharshak, N., Matsushima, G.K., et al. NLRP12 attenuates colon inflammation by maintaining colonic microbial diversity and promoting protective commensal bacterial growth. Nat. Immunol. 18 (2017), 541–551.
21. Cho, J.H., Johnson, G.V., Glycogen synthase kinase 3beta phosphorylates tau at both primed and unprimed sites. Differential impact on microtubule binding. J. Biol. Chem. 278 (2003), 187–193.
22. Covington, D.K., Briscoe, C.A., Brown, A.J., Jayawickreme, C.K., The G-protein-coupled receptor 40 family (GPR40-GPR43) and its role in nutrient sensing. Biochem. Soc. Trans. 34 (2006), 770–773.
23. De Nardo, D., Latz, E., NLRP3 inflammasomes link inflammation and metabolic disease. Trends Immunol. 32 (2011), 373–379.
24. Deretic, V., Jiang, S., Dupont, N., Autophagy intersections with conventional and unconventional secretion in tissue development, remodeling and inflammation. Trends Cell Biol. 22 (2012), 397–406.
25. Diczfalusy, U., Olofsson, K.E., Carlsson, A.M., Gong, M., Golenbock, D.T., Rooyackers, O., Fläring, U., Björkbacka, H., Marked upregulation of cholesterol 25-hydroxylase expression by lipopolysaccharide. J. Lipid Res. 50 (2009), 2258–2264.
26. Dinarello, C.A., Donath, M.Y., Mandrup-Poulsen, T., Role of IL-1β in type 2 diabetes. Curr. Opin. Endocrinol. Diabetes Obes. 17 (2010), 314–321.
27. Ding, J., Wang, K., Liu, W., She, Y., Sun, Q., Shi, J., Wang, D.C., Shao, F., Pore-forming activity and structural autoinhibition of the gasdermin family. Nature 535 (2016), 111–116.
28. Donath, M.Y., Dalmas, É., Sauter, N.S., Böni-Schnetzler, M., Inflammation in obesity and diabetes: islet dysfunction and therapeutic opportunity. Cell Metab. 17 (2013), 860–872.
29. Dror, E., Dalmas, E., Meier, D.T., Wueest, S., Thévenet, J., Thienel, C., Timper, K., Nordmann, T.M., Traub, S., Schulze, F., et al. Postprandial macrophage-derived IL-1β stimulates insulin, and both synergistically promote glucose disposal and inflammation. Nat. Immunol. 18 (2017), 283–292.
30. Duewell, P., Kono, H., Rayner, K.J., Sirois, C.M., Vladimer, G., Bauernfeind, F.G., Abela, G.S., Franchi, L., Nuñez, G., Schnurr, M., et al. NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals. Nature 464 (2010), 1357–1361.
31. Elinav, E., Strowig, T., Kau, A.L., Henao-Mejia, J., Thaiss, C.A., Booth, C.J., Peaper, D.R., Bertin, J., Eisenbarth, S.C., Gordon, J.I., Flavell, R.A., NLRP6 inflammasome regulates colonic microbial ecology and risk for colitis. Cell 145 (2011), 745–757.
32. Everts, B., Amiel, E., Huang, S.C., Smith, A.M., Chang, C.H., Lam, W.Y., Redmann, V., Freitas, T.C., Blagih, J., van der Windt, G.J., et al. TLR-driven early glycolytic reprogramming via the kinases TBK1-IKKε supports the anabolic demands of dendritic cell activation. Nat. Immunol. 15 (2014), 323–332.
33. Fasano, A., Leaky gut and autoimmune diseases. Clin. Rev. Allergy Immunol. 42 (2012), 71–78.
34. Festi, D., Schiumerini, R., Eusebi, L.H., Marasco, G., Taddia, M., Colecchia, A., Gut microbiota and metabolic syndrome. World J. Gastroenterol. 20 (2014), 16079–16094.
35. Foster, D.W., Malonyl-CoA: the regulator of fatty acid synthesis and oxidation. J. Clin. Invest. 122 (2012), 1958–1959.
36. Franchi, L., Eigenbrod, T., Núñez, G., Cutting edge: TNF-alpha mediates sensitization to ATP and silica via the NLRP3 inflammasome in the absence of microbial stimulation. J. Immunol. 183 (2009), 792–796.
37. Freigang, S., Ampenberger, F., Weiss, A., Kanneganti, T.D., Iwakura, Y., Hersberger, M., Kopf, M., Fatty acid-induced mitochondrial uncoupling elicits inflammasome-independent IL-1α and sterile vascular inflammation in atherosclerosis. Nat. Immunol. 14 (2013), 1045–1053.
38. Fu, P., Birukov, K.G., Oxidized phospholipids in control of inflammation and endothelial barrier. Transl. Res. 153 (2009), 166–176.
39. Fu, X., Menke, J.G., Chen, Y., Zhou, G., MacNaul, K.L., Wright, S.D., Sparrow, C.P., Lund, E.G., 27-hydroxycholesterol is an endogenous ligand for liver X receptor in cholesterol-loaded cells. J. Biol. Chem. 276 (2001), 38378–38387.
40. Fukuda, S., Toh, H., Hase, K., Oshima, K., Nakanishi, Y., Yoshimura, K., Tobe, T., Clarke, J.M., Topping, D.L., Suzuki, T., et al. Bifidobacteria can protect from enteropathogenic infection through production of acetate. Nature 469 (2011), 543–547.
41. Gaber, T., Strehl, C., Buttgereit, F., Metabolic regulation of inflammation. Nat. Rev. Rheumatol. 13 (2017), 267–279.
42. Gao, W., Yang, J., Liu, W., Wang, Y., Shao, F., Site-specific phosphorylation and microtubule dynamics control Pyrin inflammasome activation. Proc. Natl. Acad. Sci. USA 113 (2016), E4857–E4866.
43. Garaude, J., Acín-Pérez, R., Martínez-Cano, S., Enamorado, M., Ugolini, M., Nistal-Villán, E., Hervás-Stubbs, S., Pelegrín, P., Sander, L.E., Enríquez, J.A., Sancho, D., Mitochondrial respiratory-chain adaptations in macrophages contribute to antibacterial host defense. Nat. Immunol. 17 (2016), 1037–1045.
44. Goldberg, E.L., Asher, J.L., Molony, R.D., Shaw, A.C., Zeiss, C.J., Wang, C., Morozova-Roche, L.A., Herzog, R.I., Iwasaki, A., Dixit, V.D., β-Hydroxybutyrate deactivates neutrophil NLRP3 inflammasome to relieve gout flares. Cell Rep. 18 (2017), 2077–2087.
45. Groß C.J., Mishra, R., Schneider, K.S., Médard, G., Wettmarshausen, J., Dittlein, D.C., Shi, H., Gorka, O., Koenig, P.A., Fromm, S., et al. K(+) Efflux-independent NLRP3 inflammasome activation by small molecules targeting mitochondria. Immunity 45 (2016), 761–773.
46. Guo, C., Xie, S., Chi, Z., Zhang, J., Liu, Y., Zhang, L., Zheng, M., Zhang, X., Xia, D., Ke, Y., et al. Bile acids control inflammation and metabolic disorder through inhibition of NLRP3 inflammasome. Immunity 45 (2016), 802–816.
47. Halestrap, A.P., Connern, C.P., Griffiths, E.J., Kerr, P.M., Cyclosporin A binding to mitochondrial cyclophilin inhibits the permeability transition pore and protects hearts from ischaemia/reperfusion injury. Gellerich, F.N., Zierz, S., (eds.) Detection of Mitochondrial Diseases, 1997, Springer US, 167–172.
48. Haneklaus, M., O'Neill, L.A.J., NLRP3 at the interface of metabolism and inflammation. Immunol. Rev. 265 (2015), 53–62.
49. Hao, W., Chang, C.P., Tsao, C.C., Xu, J., Oligomycin-induced bioenergetic adaptation in cancer cells with heterogeneous bioenergetic organization. J. Biol. Chem. 285 (2010), 12647–12654.
50. Hashiguchi, K., Zhang-Akiyama, Q.-M., Establishment of human cell lines lacking mitochondrial DNA. Stuart, J.A., (eds.) Mitochondrial DNA, 2009, Humana Press, 383–391.
51. Hauge, M., Vestmar, M.A., Husted, A.S., Ekberg, J.P., Wright, M.J., Di Salvo, J., Weinglass, A.B., Engelstoft, M.S., Madsen, A.N., Lückmann, M., et al. GPR40 (FFAR1) - combined Gs and Gq signaling in vitro is associated with robust incretin secretagogue action ex vivo and in vivo. Mol. Metab. 4 (2014), 3–14.
52. He, W.-T., Wan, H., Hu, L., Chen, P., Wang, X., Huang, Z., Yang, Z.H., Zhong, C.Q., Han, J., Gasdermin D is an executor of pyroptosis and required for interleukin-1β secretion. Cell Res. 25 (2015), 1285–1298.
53. He, Y., Zeng, M.Y., Yang, D., Motro, B., Núñez, G., NEK7 is an essential mediator of NLRP3 activation downstream of potassium efflux. Nature 530 (2016), 354–357.
54. Heid, M.E., Keyel, P.A., Kamga, C., Shiva, S., Watkins, S.C., Salter, R.D., Mitochondrial reactive oxygen species induces NLRP3-dependent lysosomal damage and inflammasome activation. J. Immunol. 191 (2013), 5230–5238.
55. Henao-Mejia, J., Elinav, E., Jin, C., Hao, L., Mehal, W.Z., Strowig, T., Thaiss, C.A., Kau, A.L., Eisenbarth, S.C., Jurczak, M.J., et al. Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity. Nature 482 (2012), 179–185.
56. Henriksbo, B.D., Lau, T.C., Cavallari, J.F., Denou, E., Chi, W., Lally, J.S., Crane, J.D., Duggan, B.M., Foley, K.P., Fullerton, M.D., et al. Fluvastatin causes NLRP3 inflammasome-mediated adipose insulin resistance. Diabetes 63 (2014), 3742–3747.
57. Hernandez-Cuellar, E., Tsuchiya, K., Hara, H., Fang, R., Sakai, S., Kawamura, I., Akira, S., Mitsuyama, M., Cutting edge: nitric oxide inhibits the NLRP3 inflammasome. J. Immunol. 189 (2012), 5113–5117.
58. Hess, D.T., Matsumoto, A., Kim, S.O., Marshall, H.E., Stamler, J.S., Protein S-nitrosylation: purview and parameters. Nat. Rev. Mol. Cell Biol. 6 (2005), 150–166.
59. Hirasawa, A., Tsumaya, K., Awaji, T., Katsuma, S., Adachi, T., Yamada, M., Sugimoto, Y., Miyazaki, S., Tsujimoto, G., Free fatty acids regulate gut incretin glucagon-like peptide-1 secretion through GPR120. Nat. Med. 11 (2005), 90–94.
60. Hoque, R., Farooq, A., Ghani, A., Gorelick, F., Mehal, W.Z., Lactate reduces liver and pancreatic injury in Toll-like receptor- and inflammasome-mediated inflammation via GPR81-mediated suppression of innate immunity. Gastroenterology 146 (2014), 1763–1774.
61. Hornung, V., Ablasser, A., Charrel-Dennis, M., Bauernfeind, F., Horvath, G., Caffrey, D.R., Latz, E., Fitzgerald, K.A., AIM2 recognizes cytosolic dsDNA and forms a caspase-1-activating inflammasome with ASC. Nature 458 (2009), 514–518.
62. Hotamisligil, G.S., Inflammation, metaflammation and immunometabolic disorders. Nature 542 (2017), 177–185.
63. Hu, B., Elinav, E., Huber, S., Booth, C.J., Strowig, T., Jin, C., Eisenbarth, S.C., Flavell, R.A., Inflammation-induced tumorigenesis in the colon is regulated by caspase-1 and NLRC4. Proc. Natl. Acad. Sci. USA 107 (2010), 21635–21640.
64. Hu, B., Elinav, E., Huber, S., Strowig, T., Hao, L., Hafemann, A., Jin, C., Wunderlich, C., Wunderlich, T., Eisenbarth, S.C., Flavell, R.A., Microbiota-induced activation of epithelial IL-6 signaling links inflammasome-driven inflammation with transmissible cancer. Proc. Natl. Acad. Sci. USA 110 (2013), 9862–9867.
65. Huber, S., Gagliani, N., Zenewicz, L.A., Huber, F.J., Bosurgi, L., Hu, B., Hedl, M., Zhang, W., O'Connor, W. Jr., Murphy, A.J., et al. IL-22BP is regulated by the inflammasome and modulates tumorigenesis in the intestine. Nature 491 (2012), 259–263.
66. Hue, L., Maisin, L., Rider, M.H., Palmitate inhibits liver glycolysis. Involvement of fructose 2,6-bisphosphate in the glucose/fatty acid cycle. Biochem. J. 251 (1988), 541–545.
67. Ichinohe, T., Yamazaki, T., Koshiba, T., Yanagi, Y., Mitochondrial protein mitofusin 2 is required for NLRP3 inflammasome activation after RNA virus infection. Proc. Natl. Acad. Sci. USA 110 (2013), 17963–17968.
68. Imtiyaz, H.Z., Simon, M.C., Hypoxia-inducible factors as essential regulators of inflammation. Simon, M.C., (eds.) Diverse Effects of Hypoxia on Tumor Progression. Current Topics in Microbiology and Immunology, 2010, Springer Berlin Heidelberg, 105–120.
69. Infantino, V., Iacobazzi, V., Menga, A., Avantaggiati, M.L., Palmieri, F., A key role of the mitochondrial citrate carrier (SLC25A1) in TNFα- and IFNγ-triggered inflammation. Biochim. Biophys. Acta 1839 (2014), 1217–1225.
70. Ives, A., Nomura, J., Martinon, F., Roger, T., LeRoy, D., Miner, J.N., Simon, G., Busso, N., So, A., Xanthine oxidoreductase regulates macrophage IL1β secretion upon NLRP3 inflammasome activation. Nat. Commun., 6, 2015, 6555.
71. Iyer, S.S., He, Q., Janczy, J.R., Elliott, E.I., Zhong, Z., Olivier, A.K., Sadler, J.J., Knepper-Adrian, V., Han, R., Qiao, L., et al. Mitochondrial cardiolipin is required for Nlrp3 inflammasome activation. Immunity 39 (2013), 311–323.
72. Jabaut, J., Ather, J.L., Taracanova, A., Poynter, M.E., Ckless, K., Mitochondria-targeted drugs enhance Nlrp3 inflammasome-dependent IL-1β secretion in association with alterations in cellular redox and energy status. Free Radic. Biol. Med. 60 (2013), 233–245.
73. Jang, J., Park, S., Jin Hur, H., Cho, H.J., Hwang, I., Pyo Kang, Y., Im, I., Lee, H., Lee, E., Yang, W., et al. 25-hydroxycholesterol contributes to cerebral inflammation of X-linked adrenoleukodystrophy through activation of the NLRP3 inflammasome. Nat. Commun., 7, 2016, 13129.
74. Jha, A.K., Huang, S.C., Sergushichev, A., Lampropoulou, V., Ivanova, Y., Loginicheva, E., Chmielewski, K., Stewart, K.M., Ashall, J., Everts, B., et al. Network integration of parallel metabolic and transcriptional data reveals metabolic modules that regulate macrophage polarization. Immunity 42 (2015), 419–430.
75. Jiang, W., Wu, N., Wang, X., Chi, Y., Zhang, Y., Qiu, X., Hu, Y., Li, J., Liu, Y., Dysbiosis gut microbiota associated with inflammation and impaired mucosal immune function in intestine of humans with non-alcoholic fatty liver disease. Sci. Rep., 5, 2015, 8096.
76. Johansson, M.E.V., Hansson, G.C., Immunological Aspects of Intestinal Mucus and Mucins. 2016, Nature Publishing Group, 1–11.
77. Kanneganti, T.-D., Ozören, N., Body-Malapel, M., Amer, A., Park, J.H., Franchi, L., Whitfield, J., Barchet, W., Colonna, M., Vandenabeele, P., et al. Bacterial RNA and small antiviral compounds activate caspase-1 through cryopyrin/Nalp3. Nature 440 (2006), 233–236.
78. Katsnelson, M.A., Rucker, L.G., Russo, H.M., Dubyak, G.R., K+ efflux agonists induce NLRP3 inflammasome activation independently of Ca2+ signaling. J. Immunol. 194 (2015), 3937–3952.
79. Kayagaki, N., Stowe, I.B., Lee, B.L., O'Rourke, K., Anderson, K., Warming, S., Cuellar, T., Haley, B., Roose-Girma, M., Phung, Q.T., et al. Caspase-11 cleaves gasdermin D for non-canonical inflammasome signalling. Nature 526 (2015), 666–671.
80. Keller, M., Rüegg, A., Werner, S., Beer, H.D., Active caspase-1 is a regulator of unconventional protein secretion. Cell 132 (2008), 818–831.
81. Kim, N., Lee, J.O., Lee, H.J., Kim, H.I., Kim, J.K., Lee, Y.W., Lee, S.K., Kim, S.J., Park, S.H., Kim, H.S., Endogenous ligand for GPR120, Docosahexaenoic acid, exerts benign metabolic effects on the skeletal muscles via AMP-activated protein kinase pathway. J. Biol. Chem. 290 (2015), 20438–20447.
82. L'homme, L., Esser, N., Riva, L., Scheen, A., Paquot, N., Piette, J., Legrand-Poels, S., Unsaturated fatty acids prevent activation of NLRP3 inflammasome in human monocytes/macrophages. J. Lipid Res. 54 (2013), 2998–3008.
83. Laplante, M., Sabatini, D.M., mTOR signaling in growth control and disease. Cell 149 (2012), 274–293.
84. Latz, E., Xiao, T.S., Stutz, A., Activation and regulation of the inflammasomes. Nat. Rev. Immunol. 13 (2013), 397–411.
85. Lee, W.-J., Hase, K., Gut microbiota-generated metabolites in animal health and disease. Nat. Chem. Biol. 10 (2014), 416–424.
86. Lee, G.-S., Subramanian, N., Kim, A.I., Aksentijevich, I., Goldbach-Mansky, R., Sacks, D.B., Germain, R.N., Kastner, D.L., Chae, J.J., The calcium-sensing receptor regulates the NLRP3 inflammasome through Ca2+ and cAMP. Nature 492 (2012), 123–127.
87. Lemasters, J.J., Holmuhamedov, E., Voltage-dependent anion channel (VDAC) as mitochondrial governator–thinking outside the box. Biochim. Biophys. Acta 1762 (2006), 181–190.
88. Levinsohn, J.L., Newman, Z.L., Hellmich, K.A., Fattah, R., Getz, M.A., Liu, S., Sastalla, I., Leppla, S.H., Moayeri, M., Anthrax lethal factor cleavage of Nlrp1 is required for activation of the inflammasome. PLoS Pathog., 8, 2012, e1002638.
89. Levy, M., Thaiss, C.A., Zeevi, D., Dohnalová L., Zilberman-Schapira, G., Mahdi, J.A., David, E., Savidor, A., Korem, T., Herzig, Y., et al. Microbiota-modulated metabolites shape the intestinal microenvironment by regulating NLRP6 inflammasome signaling. Cell 163 (2015), 1428–1443.
90. Levy, M., Shapiro, H., Thaiss, C.A., Elinav, E., NLRP6: a multifaceted innate immune sensor. Trends Immunol. 38 (2017), 248–260.
91. Liston, A., Masters, S.L., Homeostasis-altering molecular processes as mechanisms of inflammasome activation. Nat. Rev. Immunol. 17 (2017), 208–214.
92. Liu, X., Zhang, Z., Ruan, J., Pan, Y., Magupalli, V.G., Wu, H., Lieberman, J., Inflammasome-activated gasdermin D causes pyroptosis by forming membrane pores. Nature 535 (2016), 153–158.
93. Lordén, G., Sanjuán-García, I., de Pablo, N., Meana, C., Alvarez-Miguel, I., Pérez-García, M.T., Pelegrín, P., Balsinde, J., Balboa, M.A., Lipin-2 regulates NLRP3 inflammasome by affecting P2X7 receptor activation. J. Exp. Med. 214 (2017), 511–528.
94. Lu, B., Nakamura, T., Inouye, K., Li, J., Tang, Y., Lundbäck, P., Valdes-Ferrer, S.I., Olofsson, P.S., Kalb, T., Roth, J., et al. Novel role of PKR in inflammasome activation and HMGB1 release. Nature 488 (2012), 670–674.
95. Lumeng, C.N., Deyoung, S.M., Bodzin, J.L., Saltiel, A.R., Increased inflammatory properties of adipose tissue macrophages recruited during diet-induced obesity. Diabetes 56 (2007), 16–23.
96. Lupfer, C., Thomas, P.G., Anand, P.K., Vogel, P., Milasta, S., Martinez, J., Huang, G., Green, M., Kundu, M., Chi, H., et al. Receptor interacting protein kinase 2-mediated mitophagy regulates inflammasome activation during virus infection. Nat. Immunol. 14 (2013), 480–488.
97. Macfarlane, S.R., Seatter, M.J., Kanke, T., Hunter, G.D., Plevin, R., Proteinase-activated receptors. Pharmacol. Rev. 53 (2001), 245–282.
98. Macia, L., Tan, J., Vieira, A.T., Leach, K., Stanley, D., Luong, S., Maruya, M., Ian McKenzie, C., Hijikata, A., Wong, C., et al. Metabolite-sensing receptors GPR43 and GPR109A facilitate dietary fibre-induced gut homeostasis through regulation of the inflammasome. Nat. Commun., 6, 2015, 6734.
99. Mailloux, R.J., Harper, M.-E., Uncoupling proteins and the control of mitochondrial reactive oxygen species production. Free Radic. Biol. Med. 51 (2011), 1106–1115.
100. Malandrino, M.I., Fucho, R., Weber, M., Calderon-Dominguez, M., Mir, J.F., Valcarcel, L., Escoté X., Gómez-Serrano, M., Peral, B., Salvadó L., et al. Enhanced fatty acid oxidation in adipocytes and macrophages reduces lipid-induced triglyceride accumulation and inflammation. Am. J. Physiol. Endocrinol. Metab. 308 (2015), E756–E769.
101. Mariathasan, S., Weiss, D.S., Newton, K., McBride, J., O'Rourke, K., Roose-Girma, M., Lee, W.P., Weinrauch, Y., Monack, D.M., Dixit, V.M., Cryopyrin activates the inflammasome in response to toxins and ATP. Nature 440 (2006), 228–232.
102. McNelis, J.C., Olefsky, J.M., Macrophages, immunity, and metabolic disease. Immunity 41 (2014), 36–48.
103. Misawa, T., Takahama, M., Kozaki, T., Lee, H., Zou, J., Saitoh, T., Akira, S., Microtubule-driven spatial arrangement of mitochondria promotes activation of the NLRP3 inflammasome. Nat. Immunol. 14 (2013), 454–460.
104. Mishra, B.B., Rathinam, V.A., Martens, G.W., Martinot, A.J., Kornfeld, H., Fitzgerald, K.A., Sassetti, C.M., Nitric oxide controls the immunopathology of tuberculosis by inhibiting NLRP3 inflammasome-dependent processing of IL-1β. Nat. Immunol. 14 (2013), 52–60.
105. Moon, J.-S., Hisata, S., Park, M.A., DeNicola, G.M., Ryter, S.W., Nakahira, K., Choi, A.M., mTORC1-induced HK1-dependent glycolysis regulates NLRP3 inflammasome activation. Cell Rep. 12 (2015), 102–115.
106. Moon, J.-S., Lee, S., Park, M.A., Siempos, I.I., Haslip, M., Lee, P.J., Yun, M., Kim, C.K., Howrylak, J., Ryter, S.W., et al. UCP2-induced fatty acid synthase promotes NLRP3 inflammasome activation during sepsis. J. Clin. Invest. 125 (2015), 665–680.
107. Moon, J.-S., Nakahira, K., Chung, K.P., DeNicola, G.M., Koo, M.J., Pabón, M.A., Rooney, K.T., Yoon, J.H., Ryter, S.W., Stout-Delgado, H., Choi, A.M., NOX4-dependent fatty acid oxidation promotes NLRP3 inflammasome activation in macrophages. Nat. Med. 22 (2016), 1002–1012.
108. Mortimer, L., Moreau, F., MacDonald, J.A., Chadee, K., NLRP3 inflammasome inhibition is disrupted in a group of auto-inflammatory disease CAPS mutations. Nat. Immunol. 17 (2016), 1176–1186.
109. Muñoz, M., Eidenschenk, C., Ota, N., Wong, K., Lohmann, U., Kühl, A.A., Wang, X., Manzanillo, P., Li, Y., Rutz, S., et al. Interleukin-22 induces interleukin-18 expression from epithelial cells during intestinal infection. Immunity 42 (2015), 321–331.
110. + efflux is the common trigger of NLRP3 inflammasome activation by bacterial toxins and particulate matter. Immunity 38 (2013), 1142–1153.
111. Murphy, M.P., How mitochondria produce reactive oxygen species. Biochem. J. 417 (2009), 1–13.
112. Nakahira, K., Haspel, J.A., Rathinam, V.A., Lee, S.J., Dolinay, T., Lam, H.C., Englert, J.A., Rabinovitch, M., Cernadas, M., Kim, H.P., et al. Autophagy proteins regulate innate immune responses by inhibiting the release of mitochondrial DNA mediated by the NALP3 inflammasome. Nat. Immunol. 12 (2011), 222–230.
113. Neves, A.L., Coelho, J., Couto, L., Leite-Moreira, A., Roncon-Albuquerque, R. Jr., Metabolic endotoxemia: a molecular link between obesity and cardiovascular risk. J. Mol. Endocrinol. 51 (2013), R51–R64.
114. Newman, J.C., Verdin, E., Ketone bodies as signaling metabolites. Trends Endocrinol. Metab. 25 (2014), 42–52.
115. Newsholme, E.A., Sugden, P.H., Williams, T., Effect of citrate on the activities of 6-phosphofructokinase from nervous and muscle tissues from different animals and its relationships to the regulation of glycolysis. Biochem. J. 166 (1977), 123–129.
116. Nomura, J., So, A., Tamura, M., Busso, N., Intracellular ATP decrease mediates NLRP3 inflammasome activation upon nigericin and crystal stimulation. J. Immunol. 195 (2015), 5718–5724.
117. Normand, S., Delanoye-Crespin, A., Bressenot, A., Huot, L., Grandjean, T., Peyrin-Biroulet, L., Lemoine, Y., Hot, D., Chamaillard, M., Nod-like receptor pyrin domain-containing protein 6 (NLRP6) controls epithelial self-renewal and colorectal carcinogenesis upon injury. Proc. Natl. Acad. Sci. USA 108 (2011), 9601–9606.
118. O'Neill, L.A.J., A broken krebs cycle in macrophages. Immunity 42 (2015), 393–394.
119. O'Neill, L.A.J., Kishton, R.J., Rathmell, J., A guide to immunometabolism for immunologists. Nat. Rev. Immunol. 16 (2016), 553–565.
120. Oskolkova, O.V., Afonyushkin, T., Preinerstorfer, B., Bicker, W., von Schlieffen, E., Hainzl, E., Demyanets, S., Schabbauer, G., Lindner, W., Tselepis, A.D., et al. Oxidized phospholipids are more potent antagonists of lipopolysaccharide than inducers of inflammation. J. Immunol. 185 (2010), 7706–7712.
121. Owen, O.E., Kalhan, S.C., Hanson, R.W., The key role of anaplerosis and cataplerosis for citric acid cycle function. J. Biol. Chem. 277 (2002), 30409–30412.
122. Paradies, G., et al. Functional role of cardiolipin in mitochondrial bioenergetics. Biochim. Biophys. Acta 1837 (2014), 408–417.
123. Park, K., Scott, A.L., Cholesterol 25-hydroxylase production by dendritic cells and macrophages is regulated by type I interferons. J. Leukoc. Biol. 88 (2010), 1081–1087.
124. Park, S., Juliana, C., Hong, S., Datta, P., Hwang, I., Fernandes-Alnemri, T., Yu, J.W., Alnemri, E.S., The mitochondrial antiviral protein MAVS associates with NLRP3 and regulates its inflammasome activity. J. Immunol. 191 (2013), 4358–4366.
125. Park, Y.H., Wood, G., Kastner, D.L., Chae, J.J., Pyrin inflammasome activation and RhoA signaling in the autoinflammatory diseases FMF and HIDS. Nat. Immunol. 17 (2016), 914–921.
126. Pastorino, J.G., Hoek, J.B., Regulation of hexokinase binding to VDAC. J. Bioenerg. Biomembr. 40 (2008), 171–182.
127. Pétrilli, V., Papin, S., Dostert, C., Mayor, A., Martinon, F., Tschopp, J., Activation of the NALP3 inflammasome is triggered by low intracellular potassium concentration. Cell Death Differ. 14 (2007), 1583–1589.
128. Qu, Y., Misaghi, S., Izrael-Tomasevic, A., Newton, K., Gilmour, L.L., Lamkanfi, M., Louie, S., Kayagaki, N., Liu, J., Kömüves, L., et al. Phosphorylation of NLRC4 is critical for inflammasome activation. Nature 490 (2012), 539–542.
129. Rajamäki, K., Lappalainen, J., Oörni, K., Välimäki, E., Matikainen, S., Kovanen, P.T., Eklund, K.K., Cholesterol crystals activate the NLRP3 inflammasome in human macrophages: a novel link between cholesterol metabolism and inflammation. PLoS ONE, 5, 2010, e11765.
130. Reboldi, A., Dang, E.V., McDonald, J.G., Liang, G., Russell, D.W., Cyster, J.G., Inflammation. 25-Hydroxycholesterol suppresses interleukin-1-driven inflammation downstream of type I interferon. Science 345 (2014), 679–684.
131. Saddoughi, S.A., Gencer, S., Peterson, Y.K., Ward, K.E., Mukhopadhyay, A., Oaks, J., Bielawski, J., Szulc, Z.M., Thomas, R.J., Selvam, S.P., et al. Sphingosine analogue drug FTY720 targets I2PP2A/SET and mediates lung tumour suppression via activation of PP2A-RIPK1-dependent necroptosis. EMBO Mol. Med. 5 (2013), 105–121.
132. Samstad, E.O., Niyonzima, N., Nymo, S., Aune, M.H., Ryan, L., Bakke, S.S., Lappegård, K.T., Brekke, O.L., Lambris, J.D., Damås, J.K., et al. Cholesterol crystals induce complement-dependent inflammasome activation and cytokine release. J. Immunol. 192 (2014), 2837–2845.
133. Sánchez, C., Pérez, M., Avila, J., GSK3beta-mediated phosphorylation of the microtubule-associated protein 2C (MAP2C) prevents microtubule bundling. Eur. J. Cell Biol. 79 (2000), 252–260.
134. Sanman, L.E., Qian, Y., Eisele, N.A., Ng, T.M., van der Linden, W.A., Monack, D.M., Weerapana, E., Bogyo, M., Disruption of glycolytic flux is a signal for inflammasome signaling and pyroptotic cell death. eLife, 5, 2016, e13663.
135. Schmid-Burgk, J.L., Chauhan, D., Schmidt, T., Ebert, T.S., Reinhardt, J., Endl, E., Hornung, V., A genome-wide CRISPR (clustered regularly interspaced short palindromic repeats) screen identifies NEK7 as an essential component of NLRP3 inflammasome activation. J. Biol. Chem. 291 (2016), 103–109.
136. Schulz, M.D., Atay, C., Heringer, J., Romrig, F.K., Schwitalla, S., Aydin, B., Ziegler, P.K., Varga, J., Reindl, W., Pommerenke, C., et al. High-fat-diet-mediated dysbiosis promotes intestinal carcinogenesis independently of obesity. Nature 514 (2014), 508–512.
137. Sekirov, I., Russell, S.L., Antunes, L.C., Finlay, B.B., Gut microbiota in health and disease. Physiol. Rev. 90 (2010), 859–904.
138. Shao, W., Yeretssian, G., Doiron, K., Hussain, S.N., Saleh, M., The caspase-1 digestome identifies the glycolysis pathway as a target during infection and septic shock. J. Biol. Chem. 282 (2007), 36321–36329.
139. Shi, J., Zhao, Y., Wang, Y., Gao, W., Ding, J., Li, P., Hu, L., Shao, F., Inflammatory caspases are innate immune receptors for intracellular LPS. Nature 514 (2014), 187–192.
140. Shi, J., Zhao, Y., Wang, K., Shi, X., Wang, Y., Huang, H., Zhuang, Y., Cai, T., Wang, F., Shao, F., Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death. Nature 526 (2015), 660–665.
141. Shi, H., Wang, Y., Li, X., Zhan, X., Tang, M., Fina, M., Su, L., Pratt, D., Bu, C.H., Hildebrand, S., et al. NLRP3 activation and mitosis are mutually exclusive events coordinated by NEK7, a new inflammasome component. Nat. Immunol. 17 (2016), 250–258.
142. Shimada, K., Crother, T.R., Karlin, J., Dagvadorj, J., Chiba, N., Chen, S., Ramanujan, V.K., Wolf, A.J., Vergnes, L., Ojcius, D.M., et al. Oxidized mitochondrial DNA activates the NLRP3 inflammasome during apoptosis. Immunity 36 (2012), 401–414.
143. Shoshan-Barmatz, V., Israelson, A., Brdiczka, D., Sheu, S.S., The voltage-dependent anion channel (VDAC): function in intracellular signalling, cell life and cell death. Curr. Pharm. Des. 12 (2006), 2249–2270.
144. Shreiner, A.B., Kao, J.Y., Young, V.B., The gut microbiome in health and in disease. Curr. Opin. Gastroenterol. 31 (2015), 69–75.
145. Sokolowska, M., Chen, L.Y., Liu, Y., Martinez-Anton, A., Qi, H.Y., Logun, C., Alsaaty, S., Park, Y.H., Kastner, D.L., Chae, J.J., Shelhamer, J.H., Prostaglandin E2 inhibits NLRP3 inflammasome activation through EP4 receptor and intracellular cyclic AMP in human macrophages. J. Immunol. 194 (2015), 5472–5487.
146. Spiro, R.G., The effect of N-acetylglucosamine and glucosamine on carbohydrate metabolism in rat liver slices. J. Biol. Chem. 233 (1958), 546–550.
147. Stancu, C., Sima, A., Statins: mechanism of action and effects. J. Cell. Mol. Med. 5 (2001), 378–387.
148. Stutz, A., Kolbe, C.C., Stahl, R., Horvath, G.L., Franklin, B.S., van Ray, O., Brinkschulte, R., Geyer, M., Meissner, F., Latz, E., NLRP3 inflammasome assembly is regulated by phosphorylation of the pyrin domain. J. Exp. Med. 214 (2017), 1725–1736.
149. Subramanian, N., Natarajan, K., Clatworthy, M.R., Wang, Z., Germain, R.N., The adaptor MAVS promotes NLRP3 mitochondrial localization and inflammasome activation. Cell 153 (2013), 348–361.
150. Sun, Y., Zhang, M., Chen, C.C., Gillilland, M. 3rd, Sun, X., El-Zaatari, M., Huffnagle, G.B., Young, V.B., Zhang, J., Hong, S.C., et al. Stress-induced corticotropin-releasing hormone-mediated NLRP6 inflammasome inhibition and transmissible enteritis in mice. Gastroenterology 144 (2013), 1478–1487 1487.e1–1487.e8.
151. Tanji, H., Ohto, U., Shibata, T., Taoka, M., Yamauchi, Y., Isobe, T., Miyake, K., Shimizu, T., Toll-like receptor 8 senses degradation products of single-stranded RNA. Nat. Struct. Mol. Biol. 22 (2015), 109–115.
152. Tannahill, G.M., Curtis, A.M., Adamik, J., Palsson-McDermott, E.M., McGettrick, A.F., Goel, G., Frezza, C., Bernard, N.J., Kelly, B., Foley, N.H., et al. Succinate is an inflammatory signal that induces IL-1β through HIF-1α. Nature 496 (2013), 238–242.
153. Thangaraju, M., Cresci, G.A., Liu, K., Ananth, S., Gnanaprakasam, J.P., Browning, D.D., Mellinger, J.D., Smith, S.B., Digby, G.J., Lambert, N.A., et al. GPR109A is a G-protein-coupled receptor for the bacterial fermentation product butyrate and functions as a tumor suppressor in colon. Cancer Res. 69 (2009), 2826–2832.
154. Tocco-Bradley, R., Georgieff, M., Jones, C.T., Moldawer, L.L., Dinarello, C.A., Blackburn, G.L., Bistrian, B.R., Changes in energy expenditure and fat metabolism in rats infused with interleukin-1. Eur. J. Clin. Invest. 17 (1987), 504–510.
155. Tremaroli, V., Bäckhed, F., Functional interactions between the gut microbiota and host metabolism. Nature 489 (2012), 242–249.
156. Ubeda, C., Djukovic, A., Isaac, S., Roles of the intestinal microbiota in pathogen protection. Clin. Transl. Immunology, 6, 2017, e128.
157. Vaarala, O., Atkinson, M.A., Neu, J., The “perfect storm” for type 1 diabetes: the complex interplay between intestinal microbiota, gut permeability, and mucosal immunity. Diabetes 57 (2008), 2555–2562.
158. van de Wier, B., Balk, J.M., Haenen, G.R., Giamouridis, D., Bakker, J.A., Bast, B.C., den Hartog, G.J., Koek, G.H., Bast, A., Elevated citrate levels in non-alcoholic fatty liver disease: the potential of citrate to promote radical production. FEBS Lett. 587 (2013), 2461–2466.
159. van der Burgh, R., Nijhuis, L., Pervolaraki, K., Compeer, E.B., Jongeneel, L.H., van Gijn, M., Coffer, P.J., Murphy, M.P., Mastroberardino, P.G., Frenkel, J., Boes, M., Defects in mitochondrial clearance predispose human monocytes to interleukin-1β hypersecretion. J. Biol. Chem. 289 (2014), 5000–5012.
160. Vandanmagsar, B., Youm, Y.H., Ravussin, A., Galgani, J.E., Stadler, K., Mynatt, R.L., Ravussin, E., Stephens, J.M., Dixit, V.D., The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance. Nat. Med. 17 (2011), 179–188.
161. Wang, X., Zhang, X., Huang, Z., Wu, D., Liu, B., Zhang, R., Yin, R., Hou, T., Jian, C., Xu, J., et al. Protons Trigger Mitochondrial Flashes. Biophys. J. 111 (2016), 386–394.
162. Wang, Y., Ning, X., Gao, P., Wu, S., Sha, M., Lv, M., Zhou, X., Gao, J., Fang, R., Meng, G., et al. Inflammasome activation triggers caspase-1-mediated cleavage of cGAS to regulate responses to DNA virus infection. Immunity 46 (2017), 393–404.
163. Weinberg, S.E., Sena, L.A., Chandel, N.S., Mitochondria in the regulation of innate and adaptive immunity. Immunity 42 (2015), 406–417.
164. Wen, H., Gris, D., Lei, Y., Jha, S., Zhang, L., Huang, M.T., Brickey, W.J., Ting, J.P., Fatty acid-induced NLRP3-ASC inflammasome activation interferes with insulin signaling. Nat. Immunol. 12 (2011), 408–415.
165. Wen, H., Ting, J.P.-Y., O'Neill, L.A.J., A role for the NLRP3 inflammasome in metabolic diseases–did Warburg miss inflammation?. Nat. Immunol. 13 (2012), 352–357.
166. Williams-Bey, Y., Boularan, C., Vural, A., Huang, N.N., Hwang, I.Y., Shan-Shi, C., Kehrl, J.H., Omega-3 free fatty acids suppress macrophage inflammasome activation by inhibiting NF-κB activation and enhancing autophagy. PLoS ONE, 9, 2014, e97957.
167. Wlodarska, M., Thaiss, C.A., Nowarski, R., Henao-Mejia, J., Zhang, J.P., Brown, E.M., Frankel, G., Levy, M., Katz, M.N., Philbrick, W.M., et al. NLRP6 inflammasome orchestrates the colonic host-microbial interface by regulating goblet cell mucus secretion. Cell 156 (2014), 1045–1059.
168. Wolf, A.J., Reyes, C.N., Liang, W., Becker, C., Shimada, K., Wheeler, M.L., Cho, H.C., Popescu, N.I., Coggeshall, K.M., Arditi, M., Underhill, D.M., Hexokinase is an innate immune receptor for the detection of bacterial peptidoglycan. Cell 166 (2016), 624–636.
169. Wynosky-Dolfi, M.A., Snyder, A.G., Philip, N.H., Doonan, P.J., Poffenberger, M.C., Avizonis, D., Zwack, E.E., Riblett, A.M., Hu, B., Strowig, T., et al. Oxidative metabolism enables Salmonella evasion of the NLRP3 inflammasome. J. Exp. Med. 211 (2014), 653–668.
170. Xie, M., Yu, Y., Kang, R., Zhu, S., Yang, L., Zeng, L., Sun, X., Yang, M., Billiar, T.R., Wang, H., et al. PKM2-dependent glycolysis promotes NLRP3 and AIM2 inflammasome activation. Nat. Commun., 7, 2016, 13280.
171. Xu, J.-F., Washko, G.R., Nakahira, K., Hatabu, H., Patel, A.S., Fernandez, I.E., Nishino, M., Okajima, Y., Yamashiro, T., Ross, J.C., et al., COPDGene Investigators. Statins and pulmonary fibrosis: the potential role of NLRP3 inflammasome activation. Am. J. Respir. Crit. Care Med. 185 (2012), 547–556.
172. Yamada, T., Takahashi, D., Hase, K., The diet-microbiota-metabolite axis regulates the host physiology. J. Biochem. 160 (2016), 1–10.
173. Yamasaki, K., Muto, J., Taylor, K.R., Cogen, A.L., Audish, D., Bertin, J., Grant, E.P., Coyle, A.J., Misaghi, A., Hoffman, H.M., Gallo, R.L., NLRP3/cryopyrin is necessary for interleukin-1β (IL-1β) release in response to hyaluronan, an endogenous trigger of inflammation in response to injury. J. Biol. Chem. 284 (2009), 12762–12771.
174. Yan, Y., Jiang, W., Spinetti, T., Tardivel, A., Castillo, R., Bourquin, C., Guarda, G., Tian, Z., Tschopp, J., Zhou, R., Omega-3 fatty acids prevent inflammation and metabolic disorder through inhibition of NLRP3 inflammasome activation. Immunity 38 (2013), 1154–1163.
175. Yan, Y., Jiang, W., Liu, L., Wang, X., Ding, C., Tian, Z., Zhou, R., Dopamine controls systemic inflammation through inhibition of NLRP3 inflammasome. Cell 160 (2015), 62–73.
176. Yang, D., He, Y., Muñoz-Planillo, R., Liu, Q., Núñez, G., Caspase-11 requires the pannexin-1 channel and the purinergic P2X7 pore to mediate pyroptosis and endotoxic shock. Immunity 43 (2015), 923–932.
177. Yang, L., Venneti, S., Nagrath, D., Glutaminolysis: a hallmark of cancer metabolism. Annu. Rev. Biomed. Eng., 2017, 10.1146/annurev-bioeng-071516-044546.
178. Yeon, S.H., et al. Oxidized phosphatidylcholine induces the activation of NLRP3 inflammasome in macrophages. J. Leukoc. Biol. 101 (2016), 205–215.
179. Yoshizumi, T., Ichinohe, T., Sasaki, O., Otera, H., Kawabata, S., Mihara, K., Koshiba, T., Influenza A virus protein PB1-F2 translocates into mitochondria via Tom40 channels and impairs innate immunity. Nat. Commun., 5, 2014, 4713.
180. Youm, Y.-H., Nguyen, K.Y., Grant, R.W., Goldberg, E.L., Bodogai, M., Kim, D., D'Agostino, D., Planavsky, N., Lupfer, C., Kanneganti, T.D., et al. The ketone metabolite β-hydroxybutyrate blocks NLRP3 inflammasome-mediated inflammatory disease. Nat. Med. 21 (2015), 263–269.
181. Yu, J., Nagasu, H., Murakami, T., Hoang, H., Broderick, L., Hoffman, H.M., Horng, T., Inflammasome activation leads to Caspase-1-dependent mitochondrial damage and block of mitophagy. Proc. Natl. Acad. Sci. USA 111 (2014), 15514–15519.
182. Zanoni, I., Tan, Y., Di Gioia, M., Broggi, A., Ruan, J., Shi, J., Donado, C.A., Shao, F., Wu, H., Springstead, J.R., Kagan, J.C., An endogenous caspase-11 ligand elicits interleukin-1 release from living dendritic cells. Science 352 (2016), 1232–1236.
183. Zhang, Z., Ohto, U., Shibata, T., Krayukhina, E., Taoka, M., Yamauchi, Y., Tanji, H., Isobe, T., Uchiyama, S., Miyake, K., Shimizu, T., Structural analysis reveals that Toll-like receptor 7 is a dual receptor for guanosine and single-stranded RNA. Immunity 45 (2016), 737–748.
184. Zhao, Y., Shao, F., The NAIP-NLRC4 inflammasome in innate immune detection of bacterial flagellin and type III secretion apparatus. Immunol. Rev. 265 (2015), 85–102.
185. Zhao, Y., Peng, J., Lu, C., Hsin, M., Mura, M., Wu, L., Chu, L., Zamel, R., Machuca, T., Waddell, T., et al. Metabolomic heterogeneity of pulmonary arterial hypertension. PLoS ONE, 9, 2014, e88727.
186. Zhong, Z., Zhai, Y., Liang, S., Mori, Y., Han, R., Sutterwala, F.S., Qiao, L., TRPM2 links oxidative stress to NLRP3 inflammasome activation. Nat. Commun., 4, 2013, 1611.
187. Zhong, Z., Umemura, A., Sanchez-Lopez, E., Liang, S., Shalapour, S., Wong, J., He, F., Boassa, D., Perkins, G., Ali, S.R., et al. NF-κB restricts inflammasome activation via elimination of damaged mitochondria. Cell 164 (2016), 896–910.
188. Zhou, R., Tardivel, A., Thorens, B., Choi, I., Tschopp, J., Thioredoxin-interacting protein links oxidative stress to inflammasome activation. Nat. Immunol. 11 (2010), 136–140.
189. Zhou, R., Yazdi, A.S., Menu, P., Tschopp, J., A role for mitochondria in NLRP3 inflammasome activation. Nature 469 (2011), 221–225.
190. Zimmer, S., Grebe, A., Bakke, S.S., Bode, N., Halvorsen, B., Ulas, T., Skjelland, M., De Nardo, D., Labzin, L.I., Kerksiek, A., et al. Cyclodextrin promotes atherosclerosis regression via macrophage reprogramming. Sci. Transl. Med., 8, 2016, 333ra50.